We are searching data for your request:
Study: Psychopharmaceutical prescriptions in children and adolescents are increasing
Antipsychotic drug administrations in children and adolescents are also increasing continuously in Germany. This was the result of a team of researchers who evaluated current data.
Prescription of antipsychotics in children and adolescents has increased significantly in the United States and Europe in recent years. The side effects have not yet been sufficiently researched. A group of scientists has now analyzed data for Germany. They come to the conclusion that the antipsychotic prescriptions for children and adolescents have also increased in Germany in recent years.
The researchers evaluated BARMER GEK data from the years 2005–2012. To this end, the antipsychotic prescriptions for children and adolescents (ages: 0–19 years) were analyzed over this period according to age, gender, prescribed substance, prescribing group and trends over time.
The proportion of children or adolescents who were prescribed an antipsychotic drug increased from 0.23% (2005) to 0.32% (2012). The increase in antipsychotic prescriptions was particularly pronounced in the age group of 10 to 14 year olds (0.24% to 0.43%) and 15 to 19 year olds (0.34% to 0.54%). Most of the prescriptions were made by child and adolescent psychiatrists or pediatricians; the most commonly prescribed substances were risperidone and pipamperon. (pm)
Photo credit: Gaby Kempf / pixelio.de